What does Aa.Pharma Oosthoven do?

Aa.Pharma Oosthoven is a pharmacy in Oud-Turnhout. Private Limited, started on 17 December 1991, 1 establishment.

What is the address of Aa.Pharma Oosthoven?

The registered office of Aa.Pharma Oosthoven is located at Polderstraat 32 box 2, 2360 Oud-Turnhout.

Is Aa.Pharma Oosthoven still active?

Yes. According to the CBE (29 October 2026) Aa.Pharma Oosthoven is active, legal situation “Normale toestand”, started on 17 December 1991.

Is Aa.Pharma Oosthoven registered on Peppol?

Yes, Aa.Pharma Oosthoven is registered on the Peppol network with ID 0208:0445936714.

What is the enterprise number of Aa.Pharma Oosthoven?

The enterprise number of Aa.Pharma Oosthoven is BE0445936714.

When was Aa.Pharma Oosthoven founded?

Aa.Pharma Oosthoven was founded on 17 December 1991.

Who are the directors of Aa.Pharma Oosthoven?

According to the 2025 annual accounts, the directors of Aa.Pharma Oosthoven are: Annelies Robrechts, Ruth Smits, Diederik Stas.

Is Aa.Pharma Oosthoven a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 December 1991; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did Aa.Pharma Oosthoven make in 2025?

Aa.Pharma Oosthoven posted a profit after taxes of € 52,364 in financial year 2025.

What is the revenue of Aa.Pharma Oosthoven?

As a small company, Aa.Pharma Oosthoven is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 258,316.

Aa.Pharma Oosthoven (Private Limited) - Oud-Turnhout

Dossier Aa.Pharma Oosthoven, printed on 29 October 2026 from databakkes.be/en/0445936714/aa-pharma-oosthoven. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Aa.Pharma Oosthoven from Oud-Turnhout, company number BE0445936714, closed financial year 2025 with a result of € 52,364 after tax. For that financial year Aa.Pharma Oosthoven recorded a gross margin of € 258,316 and equity of € 179,025. Compared with financial year 2024, the result moved from € 25,045 to € 52,364. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 6, 2026.

What it is worth Healthy

€ 179,025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 52,364

▲ 109% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 111,048

▲ 87% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 52,364 paid out

100 % of the profit went to the shareholders, mostly to PROSANA (100 % of the shares). That is where the money ends up.

People and assets in 2025

Wage cost

€ 140,480

▲ 7% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 181,081

▼ 11% vs 2024

€ 21,109 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 145,674

▼ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 17,140

▲ 15% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 264,103 Gross margin 2022: € 264,103 First fiscal year in the series	€ 222,602 Gross margin 2023: € 222,602 ▼ 16% vs 2022 (€ 264,103) Unfavourable step	€ 213,853 Gross margin 2024: € 213,853 ▼ 4% vs 2023 (€ 222,602) Unfavourable step	€ 258,316 Gross margin 2025: € 258,316 ▲ 21% vs 2024 (€ 213,853) Favourable step	▲ 21%
Profit after taxes	€ 122,834 Profit after taxes 2022: € 122,834 First fiscal year in the series	€ 90,205 Profit after taxes 2023: € 90,205 ▼ 27% vs 2022 (€ 122,834) Unfavourable step	€ 25,045 Profit after taxes 2024: € 25,045 ▼ 72% vs 2023 (€ 90,205) Unfavourable step	€ 52,364 Profit after taxes 2025: € 52,364 ▲ 109% vs 2024 (€ 25,045) Favourable step	▲ 109%
Equity	€ 179,025 Equity 2022: € 179,025 First fiscal year in the series	€ 179,025 Equity 2023: € 179,025 Unchanged (€ 179,025) Unchanged	€ 179,025 Equity 2024: € 179,025 Unchanged (€ 179,025) Unchanged	€ 179,025 Equity 2025: € 179,025 Unchanged (€ 179,025) Unchanged
Total debts	€ 601,652 Total debts 2022: € 601,652 First fiscal year in the series	€ 468,605 Total debts 2023: € 468,605 ▼ 22% vs 2022 (€ 601,652) Favourable step	€ 446,461 Total debts 2024: € 446,461 ▼ 5% vs 2023 (€ 468,605) Favourable step	€ 484,509 Total debts 2025: € 484,509 ▲ 9% vs 2024 (€ 446,461) Unfavourable step	▲ 9%
Cash	€ 47,073 Cash 2022: € 47,073 First fiscal year in the series	€ 60,521 Cash 2023: € 60,521 ▲ 29% vs 2022 (€ 47,073) Favourable step	€ 59,376 Cash 2024: € 59,376 ▼ 2% vs 2023 (€ 60,521) Unfavourable step	€ 111,048 Cash 2025: € 111,048 ▲ 87% vs 2024 (€ 59,376) Favourable step	▲ 87%
Land & buildings	€ 283,350 Land & buildings 2022: € 283,350 First fiscal year in the series	€ 266,753 Land & buildings 2023: € 266,753 ▼ 6% vs 2022 (€ 283,350) Unchanged	€ 259,047 Land & buildings 2024: € 259,047 ▼ 3% vs 2023 (€ 266,753) Unchanged	€ 247,126 Land & buildings 2025: € 247,126 ▼ 5% vs 2024 (€ 259,047) Unchanged	▼ 5%
Retained profit	€ 160,433 Retained profit 2022: € 160,433 First fiscal year in the series	€ 160,433 Retained profit 2023: € 160,433 Unchanged (€ 160,433) Unchanged	€ 160,433 Retained profit 2024: € 160,433 Unchanged (€ 160,433) Unchanged	€ 160,433 Retained profit 2025: € 160,433 Unchanged (€ 160,433) Unchanged
Dividend	€ 197,500 Dividend 2022: € 197,500 First fiscal year in the series	€ 90,205 Dividend 2023: € 90,205 ▼ 54% vs 2022 (€ 197,500) Unchanged	€ 25,045 Dividend 2024: € 25,045 ▼ 72% vs 2023 (€ 90,205) Unchanged	€ 52,364 Dividend 2025: € 52,364 ▲ 109% vs 2024 (€ 25,045) Unchanged	▲ 109%
Bank debt	€ 273,377 Bank debt 2022: € 273,377 First fiscal year in the series	€ 228,744 Bank debt 2023: € 228,744 ▼ 16% vs 2022 (€ 273,377) Favourable step	€ 204,576 Bank debt 2024: € 204,576 ▼ 11% vs 2023 (€ 228,744) Favourable step	€ 181,081 Bank debt 2025: € 181,081 ▼ 11% vs 2024 (€ 204,576) Favourable step	▼ 11%
Balance sheet total	€ 780,677 Balance sheet total 2022: € 780,677 First fiscal year in the series	€ 647,630 Balance sheet total 2023: € 647,630 ▼ 17% vs 2022 (€ 780,677) Unchanged	€ 625,486 Balance sheet total 2024: € 625,486 ▼ 3% vs 2023 (€ 647,630) Unchanged	€ 663,534 Balance sheet total 2025: € 663,534 ▲ 6% vs 2024 (€ 625,486) Unchanged	▲ 6%

Key figures of Aa.Pharma Oosthoven, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Aa.Pharma Oosthoven?

What happened at Aa.Pharma Oosthoven in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 6, 2026 New annual accounts for financial year 2025: profit of € 52,364 (▲ 109% vs 2024). Source: NBB ↗
Jan 31, 1992 New establishment in Oud-Turnhout. KBO
Dec 17, 1991 Start of the company according to the CBE. KBO

In short

From € 122,834 profit in 2022 to € 52,364 profit in 2025.

Paid € 96,728 in corporate taxes since 2022.

Best year ever: 2022, with € 122,834 profit.

Paid out € 365,114 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

PROSANA 100%

The stake of PROSANA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Aa.Pharma Oosthoven

Behind Aa.Pharma Oosthoven are Annelies Robrechts, Ruth Smits and Diederik Stas. The shares are held by PROSANA (100%).

Directors

According to the 2025 annual accounts

Annelies Robrechts

Director

Also active at: Aa.Pharma Oud-Turnhout, Aa.Pharma Turnhout, JacoRob, PROSANA

Ruth Smits

Director

Also active at: Aa.Pharma Oud-Turnhout, Aa.Pharma Turnhout, ARUCAREA, PROSANA

Diederik Stas

Director

Also active at: Aa.Pharma Oud-Turnhout, Aa.Pharma Turnhout, PROSANA

Shareholders

PROSANA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Polderstraat 32 box 2

2360 Oud-Turnhout

2.055.964.488

Polderstraat 32

2360 Oud-Turnhout

Active since 31 January 1992

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Kempische Farmaceutische Kring

DR. GEYSKENS LEENTJE

€ 22,753 gross margin · 2025

DS Pharma Services

€ 56,230 gross margin · 2026

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0445.936.714

VAT number

BE 0445.936.714

Registered office

Polderstraat 32 bus 2, 2360 Oud-Turnhout

Names & denominations

Aa.Pharma Oosthoven

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 December 1991

Peppol

Active · Active since 9 Sept 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Aa.Pharma Oosthoven

Financials

What happened to Aa.Pharma Oosthoven?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions